わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/11/13 | 日証協 | 237,836株 | -16.53% | 109,400株 | -69.43% | 270,402株 | -12.89% | 9,801株 | -65.37% |
2020/11/06 | 日証協 | 284,936株 | +13.59% | 357,900株 | -23.23% | 310,401株 | +2.37% | 28,300株 | +18.41% |
2020/10/30 | 日証協 | 250,836株 | -0.4% | 466,200株 | +9.21% | 303,201株 | +1.07% | 23,900株 | -25.08% |
2020/10/23 | 日証協 | 251,836株 | -1% | 426,900株 | +54.39% | 300,001株 | +3.31% | 31,900株 | +108.5% |
2020/10/16 | 日証協 | 254,391株 | +10.9% | 276,500株 | +6.84% | 290,393株 | +1.68% | 15,300株 | -48.31% |
2020/10/09 | 日証協 | 229,391株 | +7.54% | 258,800株 | +162.47% | 285,593株 | -0.49% | 29,600株 | -18.06% |
2020/10/02 | 日証協 | 213,300株 | -10.75% | 98,600株 | +13.33% | 287,001株 | -4.49% | 36,122株 | +53.06% |
2020/09/25 | 日証協 | 239,000株 | +1.13% | 87,000株 | -13.87% | 300,492株 | +3.66% | 23,600株 | -12.3% |
2020/09/18 | 日証協 | 236,336株 | -3.38% | 101,009株 | +262.04% | 289,892株 | -5.13% | 26,909株 | -49.23% |
2020/09/11 | 日証協 | 244,591株 | -3.7% | 27,900株 | +1.09% | 305,557株 | -0.91% | 53,000株 | +238.16% |
2020/09/04 | 日証協 | 253,991株 | -10.17% | 27,600株 | -82.98% | 308,357株 | -7.51% | 15,673株 | -14.31% |
2020/08/28 | 日証協 | 282,736株 | -16.06% | 162,200株 | +966.47% | 333,402株 | -9.35% | 18,291株 | -23.79% |
2020/08/21 | 日証協 | 336,827株 | -10.57% | 15,209株 | -89.85% | 367,793株 | -9.3% | 24,000株 | +21.21% |
2020/08/14 | 日証協 | 376,627株 | -2.95% | 149,900株 | -23.56% | 405,493株 | +0.02% | 19,800株 | -34% |
2020/08/07 | 日証協 | 388,065株 | -1.62% | 196,100株 | +336.75% | 405,431株 | -1.12% | 30,000株 | -13.29% |
2020/07/22 | 日証協 | 430,665株 | -9.33% | 17,700株 | -96.12% | 452,731株 | -8.47% | 12,900株 | -60.55% |
2020/07/17 | 日証協 | 474,965株 | +9.52% | 455,900株 | +8.81% | 494,631株 | +4.08% | 32,700株 | -77.62% |
2020/07/10 | 日証協 | 433,665株 | -1.54% | 419,000株 | +121.46% | 475,231株 | -1.72% | 146,100株 | +226.12% |
2020/07/03 | 日証協 | 440,465株 | -1.74% | 189,200株 | -48.82% | 483,531株 | +4.52% | 44,800株 | -65.11% |
※株式分割は考慮していませんのでご注意ください。
Page Top